Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity

Ashutosh Tripathi, Micaela Fornabaio, Glen E. Kellogg, John T. Gupton, David A. Gewirtz, William Andrew Yeudall, Nina E. Vega, Susan L. Mooberry

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of αβ-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r2 of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.

Original languageEnglish (US)
Pages (from-to)2235-2242
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number5
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Pyrroles
Tubulin
Colchicine
Free energy
Human Activities
Structural analysis
Microtubules
Polymerization
3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester

Keywords

  • Antitubulin
  • Cytotoxicity
  • HINT
  • Molecular docking
  • Pyrroles

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Tripathi, A., Fornabaio, M., Kellogg, G. E., Gupton, J. T., Gewirtz, D. A., Yeudall, W. A., ... Mooberry, S. L. (2008). Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity. Bioorganic and Medicinal Chemistry, 16(5), 2235-2242. https://doi.org/10.1016/j.bmc.2007.11.076

Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity. / Tripathi, Ashutosh; Fornabaio, Micaela; Kellogg, Glen E.; Gupton, John T.; Gewirtz, David A.; Yeudall, William Andrew; Vega, Nina E.; Mooberry, Susan L.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 5, 01.03.2008, p. 2235-2242.

Research output: Contribution to journalArticle

Tripathi, A, Fornabaio, M, Kellogg, GE, Gupton, JT, Gewirtz, DA, Yeudall, WA, Vega, NE & Mooberry, SL 2008, 'Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity', Bioorganic and Medicinal Chemistry, vol. 16, no. 5, pp. 2235-2242. https://doi.org/10.1016/j.bmc.2007.11.076
Tripathi, Ashutosh ; Fornabaio, Micaela ; Kellogg, Glen E. ; Gupton, John T. ; Gewirtz, David A. ; Yeudall, William Andrew ; Vega, Nina E. ; Mooberry, Susan L. / Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity. In: Bioorganic and Medicinal Chemistry. 2008 ; Vol. 16, No. 5. pp. 2235-2242.
@article{212f1da810fa4a7d88b8c7ee9a62f66a,
title = "Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity",
abstract = "Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of αβ-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r2 of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.",
keywords = "Antitubulin, Cytotoxicity, HINT, Molecular docking, Pyrroles",
author = "Ashutosh Tripathi and Micaela Fornabaio and Kellogg, {Glen E.} and Gupton, {John T.} and Gewirtz, {David A.} and Yeudall, {William Andrew} and Vega, {Nina E.} and Mooberry, {Susan L.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.bmc.2007.11.076",
language = "English (US)",
volume = "16",
pages = "2235--2242",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity

AU - Tripathi, Ashutosh

AU - Fornabaio, Micaela

AU - Kellogg, Glen E.

AU - Gupton, John T.

AU - Gewirtz, David A.

AU - Yeudall, William Andrew

AU - Vega, Nina E.

AU - Mooberry, Susan L.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of αβ-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r2 of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.

AB - Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of αβ-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r2 of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.

KW - Antitubulin

KW - Cytotoxicity

KW - HINT

KW - Molecular docking

KW - Pyrroles

UR - http://www.scopus.com/inward/record.url?scp=40749153054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749153054&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2007.11.076

DO - 10.1016/j.bmc.2007.11.076

M3 - Article

VL - 16

SP - 2235

EP - 2242

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 5

ER -